Rekrutierende Studie = ; Fortlaufende Studie = ; Förderung durch ein IRDiRC-Mitglied = ; ERN-Mitglied =

Nationale klinische Studie(n)

VEREINIGTES KONIGREICH

Avon
BRISTOL

TOWER Study: A Phase III, Randomized, Open Label Study Investigating the Efficacy of the BiTE Antibody Blinatumomab Versus Standard of Care Chemotherapy in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) - UK

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

RESORCE: A randomized, double blind, placebo-controlled, multicenter phase III study of Regorafenib in patients with Hepatocellular Carcinoma after Sorafenib - UK

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

VX12-809-104: A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation - UK

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

A randomized, double-blind, parallel group, placebo-controlled trial of metformin in tuberous sclerosis complex (Phase IV) - UK

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

A Phase III randomised, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma - UK

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 2 to 17 Years, with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Followed by an Extension Phase -GB

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

A Phase 2, Randomized, Biomarker-driven, Clinical Study in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with an Exploratory Arm in Patients with Newly Diagnosed High-Risk AML -GB

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

TOPAZ-1: A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination With Gemcitabine Plus Cisplatin Versus Placebo in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers-GB

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details

VEREINIGTES KONIGREICH

Avon
BRISTOL

Treatment of Barth Syndrome by CARDIOlipin MANipulation (CARDIOMAN): A randomised placebo-controlled pilot trial conducted by the nationally commissioned Barth Syndrome Service

Bristol Royal Infirmary

University Hospitals Bristol NHS Foundation Trust HQ

Mehr Details